The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ARIAD Pharmaceuticals, Inc. (ARIA)

ARIAD Pharmaceuticals is an oncology company. Co. is engaged in development and commercialization of small-molecule drugs to treat cancer patients. Co.'s cancer medication include, Iclusig® (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with chronic myeloid leukemia, and Philadelphia chromosome-positive acute lymphoblastic leukemia. Co.'s product candidates include, AP26113, an investigational inhibitor of anaplastic lymphoma kinase. Co.s' other product candidates include Ridaforolimus, an investigational inhibitor of the mammalian target of rapamycin. ARIAD, the ARIAD logo and Iclusig are Co.s' registered trademarks and ARGENT is Co.'s trademark.

Company Name:  ARIAD Pharmaceuticals, Inc.
Sector:  Biotechnology
Number of ETFs Holding ARIA:  20
Total Market Value Held by ETFs:  $112.03M
Total Market Capitalization:  $1.87B
% of Market Cap. Held by ETFs:  6.00%
September 1, 2015    10:21 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (2.67 out of 4)
24th percentile
(ranked lower than approx. 76% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

ARIAD Pharmaceuticals, Inc. (ARIA) Page | The Online Investor | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.